Veröffentlichungen | MDC Berlin

6 Ergebnisse:

Active Filter:

10. September 2018 in Dev Cell

FACT sets a barrier for cell fate reprogramming in Caenorhabditis elegans and human cells

E. Kolundzic
A. Ofenbauer
S.I. Bulut
B. Uyar
G. Baytek
A. Sommermeier
S. Seelk
M. He
A. Hirsekorn
D. Vucicevic
A. Akalin
S. Diecke
S.A. Lacadie
B. Tursun

09. Juli 2013 in Proc Natl Acad Sci U S A

Interfering with Gal-1-mediated angiogenesis contributes to the pathogenesis of preeclampsia

N. Freitag
I. Tirado-González
G. Barrientos
F. Herse
V.L.J.L. Thijssen
S.M. Weedon-Fekjær
H. Schulz
G. Wallukat
B.F. Klapp
T. Nevers
S. Sharma
A.C. Staff
R. Dechend
S.M. Blois

01. Juli 2011 in Hypertension

Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant rats

K. Wenzel
A. Rajakumar
H. Haase
N. Geusens
N. Hubner
H. Schulz
J. Brewer
L. Roberts
C.A. Hubel
F. Herse
L. Hering
F. Qadri
C. Lindschau
G. Wallukat
R. Pijnenborg
H. Heidecke
G. Riemekasten
F.C. Luft
D.N. Muller
B. Lamarca
R. Dechend

24. Februar 2010 in PLoS ONE

alpha(1A)-adrenergic receptor-directed autoimmunity induces left ventricular damage and diastolic dysfunction in rats

K. Wenzel
G. Wallukat
F. Qadri
N. Huebner
H. Schulz
O. Hummel
F. Herse
A. Heuser
R. Fischer
H. Heidecke
F.C. Luft
D.N. Mueller
R. Dietz
R. Dechend

17. November 2008 in PLoS ONE

Potential relevance of alpha(1)-adrenergic receptor autoantibodies in refractory hypertension

K. Wenzel
H. Haase
G. Wallukat
W. Derer
S. Bartel
V. Homuth
F. Herse
N. Huebner
H. Schulz
M. Janczikowski
C. Lindschau
C. Schroeder
S. Verlohren
I. Morano
D.N. Mueller
F.C. Luft
R. Dietz
R. Dechend
P. Karczewski

01. Mai 2007 in Biol Chem

Expression of the protein phosphatase 1 inhibitor KEPI is downregulated in breast cancer cell lines and tissues and involved in the regulation of the tumor suppressor EGR1 via the MEK-ERK pathway

K. Wenzel
K. Daskalow
F. Herse
S. Seitz
U. Zacharias
J.A. Schenk
H. Schulz
N. Huebner
B. Micheel
P.M. Schlag
K.J. Osterziel
C. Ozcelik
S. Scherneck
B. Jandrig